OBJECTIVE: To examine the impact of hormones used for controlled ovarian hyperstimulation (COH) on normal and malignant breast cell growth and proliferation. DESIGN: In vitro study of cultured normal and malignant breast cell lines. SETTING: Academic medical center. PATIENT(S): None. INTERVENTION(S): Normal and malignant breast cell lines cultured in two- and three-dimensional (2D and 3D) systems and treated with follicle-stimulating hormone (FSH), luteinizing hormone (LH), or FSH with LH or human chorionic gonadotropin (hCG). MAIN OUTCOME MEASURE(S): Effects of treatment on cell proliferation in 2D culture using the MTS assay and on colony growth in 3D culture. RESULT(S): Compared with untreated cells, normal MCF-10A cells showed a decrease in proliferation and colony size when exposed to a combination of FSH and hCG. The HCC 1937 cells treated with FSH and LH also showed a decrease in colony growth but no change in proliferation. None of the treatments had an effect on the proliferation or colony size of the MCF-7 cells. CONCLUSION(S): Follicle-stimulating hormone, LH, and hCG do not appear to cause an increase in cell proliferation or colony growth in either normal or malignant mammary epithelial cell lines. The potential risk for mammary cell transformation associated with these agents may be related to indirect endocrine effects on breast cell physiology.
OBJECTIVE: To examine the impact of hormones used for controlled ovarian hyperstimulation (COH) on normal and malignant breast cell growth and proliferation. DESIGN: In vitro study of cultured normal and malignant breast cell lines. SETTING: Academic medical center. PATIENT(S): None. INTERVENTION(S): Normal and malignant breast cell lines cultured in two- and three-dimensional (2D and 3D) systems and treated with follicle-stimulating hormone (FSH), luteinizing hormone (LH), or FSH with LH or human chorionic gonadotropin (hCG). MAIN OUTCOME MEASURE(S): Effects of treatment on cell proliferation in 2D culture using the MTS assay and on colony growth in 3D culture. RESULT(S): Compared with untreated cells, normal MCF-10A cells showed a decrease in proliferation and colony size when exposed to a combination of FSH and hCG. The HCC 1937 cells treated with FSH and LH also showed a decrease in colony growth but no change in proliferation. None of the treatments had an effect on the proliferation or colony size of the MCF-7 cells. CONCLUSION(S): Follicle-stimulating hormone, LH, and hCG do not appear to cause an increase in cell proliferation or colony growth in either normal or malignant mammary epithelial cell lines. The potential risk for mammary cell transformation associated with these agents may be related to indirect endocrine effects on breast cell physiology.
Authors: Anne Cooley; Laura Matthews; Stanislav Zelivianski; Ashley Hardy; Jacqueline S Jeruss Journal: Hum Reprod Date: 2011-11-10 Impact factor: 6.918
Authors: Amanda Mawson; Angela Lai; Jason S Carroll; C Marcelo Sergio; Christopher J Mitchell; Boris Sarcevic Journal: Mol Cell Endocrinol Date: 2005-01-14 Impact factor: 4.102
Authors: T Martijn Kuijper; Kirsten Ruigrok-Ritstier; Miriam Verhoef-Post; Djura Piersma; Martijn W P Bruysters; Els M J J Berns; Axel P N Themmen Journal: Mol Cell Endocrinol Date: 2009-01-20 Impact factor: 4.102
Authors: I Pappo; L Lerner-Geva; A Halevy; L Olmer; S Friedler; A Raziel; M Schachter; R Ron-El Journal: Ann Surg Oncol Date: 2008-01-23 Impact factor: 5.344
Authors: Chantal C Orgéas; Karin Sanner; Per Hall; Peter Conner; Jan Holte; Staffan J Nilsson; Karin Sundfeldt; Ingemar Persson; Kee Seng Chia; Sara Wedren; Paul W Dickman; Kamila Czene Journal: Am J Obstet Gynecol Date: 2009-01 Impact factor: 8.661
Authors: Alison J Butt; C Elizabeth Caldon; Catriona M McNeil; Alexander Swarbrick; Elizabeth A Musgrove; Robert L Sutherland Journal: Adv Exp Med Biol Date: 2008 Impact factor: 2.622
Authors: Gernot Hudelist; Pia Wuelfing; Klaus Czerwenka; Martin Knöfler; Sandra Haider; Anneliese Fink-Retter; Daphne Gschwantler-Kaulich; Georg Pfeiler; Ernst Kubista; Christian F Singer Journal: J Cancer Res Clin Oncol Date: 2008-08-29 Impact factor: 4.553